Skip to main content
BPH ENERGY LTD logo

BPH ENERGY LTD — Investor Relations & Filings

Ticker · BPH ISIN · AU000000BPH4 ASX Financial and insurance activities
Open in API
Filings indexed 1,483 across all filing types
Latest filing 2009-09-14 Capital/Financing Update
Country AU Australia
Listing ASX BPH

About BPH ENERGY LTD

https://www.bphenergy.com.au/

BPH Energy Ltd is a diversified investment company focused on the commercialization of biomedical technologies and the exploration of energy resources. The company maintains a significant portfolio in the biotechnology sector, notably through its investment in Cortical Dynamics Ltd, which develops the Brain Anaesthesia Response Monitor (BARM) for objective measurement of anesthetic effect. In the energy sector, BPH Energy holds a substantial interest in Advent Energy Ltd, an unlisted oil and gas exploration company with assets including the PEP 11 permit in the offshore Sydney Basin. Additionally, the company has expanded its focus into sustainable energy through investments in Clean Hydrogen Technologies, which utilizes proprietary processes to produce turquoise hydrogen and solid carbon. BPH Energy aims to identify and develop high-growth opportunities within the healthcare and resource sectors to create long-term value.

Recent filings

Filing Released Lang Actions
New IPO Intended for BPH and Investment Overview 5 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is an announcement from BioPharmica dated 15 September 2009 regarding a planned IPO (Initial Public Offering) for its subsidiary Molecular Discovery Systems. It discusses the spin-off process, shareholder benefits, and business updates related to drug development and pre-clinical testing. The content focuses on corporate actions related to financing and capital structure changes, specifically the spin-off and IPO of a subsidiary. There are no detailed financial statements, quarterly or annual financial results, or management discussion of financial performance. The document is not a full annual or interim report, nor is it a regulatory filing or certification. It is an update on capital raising and corporate restructuring activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2009-09-14 English
Trading Halt 2 pages ?Kb
Regulatory Filings
2009-09-10 English
BPH Granted New Investment Opportunity 2 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is an announcement from BioPharmica Limited regarding an exclusive option to invest in Advent Energy Limited and a proposed placement of shares to raise capital. It discusses the investment opportunity, shareholder approval to be sought at the upcoming Annual General Meeting, and details about the new investment and company background. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is primarily an announcement of a capital raising and investment opportunity, not a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP). The document length is about 5,091 characters, which is sufficient for a detailed announcement but not a full report.
2009-09-10 English
Director Appointment 1 page ?Kb
Board/Management Information Classification · 100% confidence The document is a short announcement dated 31 August 2009 from BioPharmica Limited regarding the appointment of Ms Deborah Ambrosini as a Director of the company. It includes biographical details and her continuing role as Company Secretary. There is no financial data, no mention of a report or meeting, and the content clearly relates to a change in the company's board of directors. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is short and focused solely on this appointment, confirming it is not a full report or other filing type.
2009-08-30 English
Initial Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including unlisted options, and notes the director's appointment date. This is a report of personal share transactions or holdings by a company director, which fits the definition of 'Director's Dealing' filings. The document length is short and focused solely on director interests, with no financial results or other report content. Therefore, the appropriate classification is 'DIRS' (Director's Dealing).
2009-08-30 English
Resignation of Director 1 page ?Kb
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to the Australian Securities Exchange regarding the resignation of a company director, Mr. Seng Yap. It details the director's departure and expresses gratitude for his contributions. There is no financial data, no mention of a report or meeting materials, and the content focuses solely on a change in the company's board of directors. This fits the category of Board/Management Information (MANG). The document length is short and the content is specific to management changes, confirming the classification.
2009-08-25 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.